Article · Jun 2015
Conference abstractPublished 27 Oct 2014
Being-similar: From benchside to bedside
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilars has been the topic of contention, enthusiasm and research for the past couple decades both to the industry and regulatory authorities. With the introduction of latest technology at ?omics front, one could expect further deliberations in not only easy lead identification and therapeutic targets but also growing interest in biopharmaceutical companies to harness this opportunity in discovering the bio-betters or similars. Although we still debate upon the regulatory challenges of whether the innovator product and its similar is replaceable or not, there lies a bigger uncertainty at the place of its advocator i.e., the physician. Various surveys have demonstrated that physician have little clue about biosimilars and still apprehensive about its quality and safety. This behavior is not in sync with the current policy of low income countries where public health is not only a state affair but also with a limited budget. The onus is not only on the industry but also on the other stake holders to justify the very purpose of ?Being?Similar?.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 18 Jul 2016
Benchside testing of drug-eluting stent surface and geometry
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Article · 31 Dec 2025
Rapid Bedside Testing in Acute Care: The Expanding Role of Point-of-Care Diagnostics
Opinion · 12 Nov 2025
Advancing anesthesiology: From bench to bedside
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Manish Mahajan”

